NovaBay Pharmaceuticals Inc (NBY)
0.7198
+0.01
(+1.52%)
USD |
NYAM |
Nov 21, 16:00
0.7093
-0.01
(-1.46%)
After-Hours: 20:00
NovaBay Pharmaceuticals Total Liabilities (Quarterly): 2.805M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 2.805M |
| June 30, 2024 | 4.542M |
| March 31, 2024 | 5.197M |
| December 31, 2023 | 5.72M |
| September 30, 2023 | 5.815M |
| June 30, 2023 | 7.445M |
| March 31, 2023 | 5.935M |
| December 31, 2022 | 5.845M |
| September 30, 2022 | 8.592M |
| June 30, 2022 | 5.799M |
| March 31, 2022 | 7.048M |
| December 31, 2021 | 13.81M |
| September 30, 2021 | 2.875M |
| June 30, 2021 | 2.394M |
| March 31, 2021 | 3.089M |
| December 31, 2020 | 2.92M |
| September 30, 2020 | 3.20M |
| June 30, 2020 | 12.29M |
| March 31, 2020 | 9.824M |
| December 31, 2019 | 10.25M |
| September 30, 2019 | 11.68M |
| June 30, 2019 | 8.201M |
| March 31, 2019 | 8.591M |
| December 31, 2018 | 4.407M |
| September 30, 2018 | 4.306M |
| Date | Value |
|---|---|
| June 30, 2018 | 4.276M |
| March 31, 2018 | 4.952M |
| December 31, 2017 | 7.485M |
| September 30, 2017 | 9.224M |
| June 30, 2017 | 8.861M |
| March 31, 2017 | 8.326M |
| December 31, 2016 | 8.28M |
| September 30, 2016 | 8.423M |
| June 30, 2016 | 9.472M |
| March 31, 2016 | 12.23M |
| December 31, 2015 | 10.18M |
| September 30, 2015 | 6.463M |
| June 30, 2015 | 5.27M |
| March 31, 2015 | 6.006M |
| December 31, 2014 | 5.689M |
| September 30, 2014 | 5.353M |
| June 30, 2014 | 4.293M |
| March 31, 2014 | 5.349M |
| December 31, 2013 | 7.134M |
| September 30, 2013 | 6.823M |
| June 30, 2013 | 5.617M |
| March 31, 2013 | 5.079M |
| December 31, 2012 | 5.186M |
| September 30, 2012 | 6.226M |
| June 30, 2012 | 6.461M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
2.394M
Minimum
Jun 2021
13.81M
Maximum
Dec 2021
6.269M
Average
5.807M
Median
Total Liabilities (Quarterly) Benchmarks
| Palatin Technologies Inc | 11.10M |
| iBio Inc | 6.763M |
| Theriva Biologics Inc | 15.47M |
| Oragenics Inc | 2.126M |
| Nanoviricides Inc | 1.633M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 3.877M |
| Shareholders Equity (Quarterly) | 1.072M |
| Debt to Equity Ratio | 0.0476 |
| Current Ratio | 1.149 |
| Net Debt Paydown Yield | 6.74% |